Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03644563 · ClinicalTrials.gov registry record
Men and Women Offering Understanding of Throat HPV
A clinical trial of Human Papilloma Virus and Oropharyngeal Cancer, sponsored by Johns Hopkins University.
- Active
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT03644563 is a study of Human Papilloma Virus and Oropharyngeal Cancer that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 1,500 participants, above the 566-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (165% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03644563, a study of Human Papilloma Virus and Oropharyngeal Cancer, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will screen people for oncogenic oral Human Papillomavirus (HPV) infection and antibodies to form a cohort of people who may be at increased risk of HPV-oropharyngeal cancer (HPV-OPC). The investigators will follow these individuals prospectively to evaluate oncogenic oral HPV persistence, risk factors, and biomarkers for persistence.
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2017-04-03 |
| Est. Completion | 2028-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03644563
The ClinicalTrials.gov registry entry for NCT03644563 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 566-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (165% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Human Papilloma Virus appearing as the primary indexed condition, and to 0 interventions.
NCT03644563 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03644563 about?
NCT03644563 is a clinical study titled "Men and Women Offering Understanding of Throat HPV". This study will screen people for oncogenic oral Human Papillomavirus (HPV) infection and antibodies to form a cohort of people who may be at increased risk of HPV-oropharyngeal cancer (HPV-OPC). The investigators will follow these individuals prospectively to evaluate oncogenic oral HPV persistence...
What is the current status of trial NCT03644563?
This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 2017-04-03. Estimated completion is 2028-06.
What conditions does trial NCT03644563 study?
This clinical trial studies the following conditions: Human Papilloma Virus, Oropharyngeal Cancer.
Who is sponsoring clinical trial NCT03644563?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03644563 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
RECRUITING
-
Merck IIT: RRP Pembro and Lenvatinib
RECRUITING · Early Phase 1
-
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.